Development of Microbial Metabolism Gene Tests for Facilitating Precision Health and Preventive Medicine-Evaluation of TMAO Production in Human Body From High-carnitine Diet by Fecal Gbu Gene Testing
Evaluation of TMAO Production in Human Body From High-carnitine Diet by Fecal Gbu Gene Testing
1 other identifier
interventional
65
1 country
1
Brief Summary
The risk of cardiovascular diseases from red meat consumption varies among individuals due to variations in gut microbiota. L-carnitine in red meat can be converted to Trimethylamine n-oxide (TMAO) in the body by certain bacteria. Not everyone experiences a significant increase in TMAO levels after consuming carnitine. Gut microbiota differences are observed between high and low TMAO producers. The presence of the γ-butyrobetaine utilization (gbu) gene in gut microbiota is linked to TMAO production. This clinical research aims to determine if the gbu gene can predict TMAO levels after intaking a large amount of red meat.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedStudy Start
First participant enrolled
January 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
January 8, 2026
December 1, 2025
5 months
December 22, 2025
January 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Fecal gbu gene abundance measured by qPCR
up to 7-10 days
Blood TMAO level measured by LC-MS/MS
before intervention, 24hr, 48hr after intervention
Platelet aggregation of blood by Light Transmission Aggregometry
up to 7-10 days
Gut microbiome profiles measured by shotgun metagenome sequencing
up to 7-10 days
Secondary Outcomes (1)
Carnitine intake measured by 24hr dietary record
up to 7-10 days
Study Arms (1)
Red meat tolerance test
EXPERIMENTALParticipants are required to take 900 grams of beef in a meal. Before the intervention, participants are asked to dietary record two day before the intervention. Fecal samples will be collected before and after the intervention. Blood sample will be collected in 0hr, 24hr, 48hr after the intervention. Each participant needs to complete a food frequency questionnaire.
Interventions
Eligibility Criteria
You may qualify if:
- Adult with age between 18 to 70
- Willing and capable of intaking a large amount of beef
You may not qualify if:
- Antibiotics use within one month
- L-carnitine supplement use within one month
- Chronic diarrhea
- Myasthenia gravis
- Parathyroid disorders
- Chronic kidney disease
- Epilepsy
- Severe anemia
- Severe cardiovascular diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2025
First Posted
January 7, 2026
Study Start
January 15, 2026
Primary Completion (Estimated)
June 20, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
January 8, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
The data will be uploaded to be public when the research is published